The performance of tongue swabs for detection of pulmonary tuberculosis.
MPN (most probable number)
Mycobacterium tuberculosis
differentially culturable tubercle bacilli (DCTB)
tongue swabs
tuberculosis
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
03
2023
accepted:
21
08
2023
medline:
26
9
2023
pubmed:
25
9
2023
entrez:
25
9
2023
Statut:
epublish
Résumé
Oral and/or tongue swabs have demonstrated ability to detect Herein, we compared the diagnostic performance of sputum and tongue swabs using Mycobacterial Growth Indicator Tube (MGIT) assays, Auramine smear, GeneXpert and DCTB assays supplemented with or without CF. From 89 eligible participants, 83 (93%), 66 (74%) and 79 (89%) were sputum positive by MGIT, smear and GeneXpert, respectively. The corresponding tongue swabs displayed a lower sensitivity with 39 (44%), 2 (2.0%) and 18 (20%) participants respectively for the same tests. We aimed to improve the diagnostic yield by utilizing DCTB assays. Sputum samples were associated with a higher positivity rate for CF-augmented DCTB at 82/89 (92%) relative to tongue swabs at 36/89 (40%). Similarly, sputum samples had a higher positivity rate for DCTB populations that were CF-independent at 64/89 (72%) relative to tongue swabs at 26/89 (29%). DCTB positivity increased significantly, relative to MGIT culture, for tongue swabs taken from HIV-positive participants. We next tested whether the use of an alternative smear stain, DMN-Trehalose, would improve diagnostic yield but noted no substantial increase. Collectively, our data show that while tongue swabs yield lower bacterial numbers for diagnostic testing, the use of growth supplementation may improve detection of TB particularly in HIV-positive people but this requires further interrogation in larger studies.
Identifiants
pubmed: 37743867
doi: 10.3389/fcimb.2023.1186191
pmc: PMC10512057
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1186191Subventions
Organisme : Howard Hughes Medical Institute
Pays : United States
Informations de copyright
Copyright © 2023 Ealand, Sewcharran, Peters, Gordhan, Kamariza, Bertozzi, Waja, Martinson and Kana.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Sci Rep. 2019 Nov 12;9(1):16587
pubmed: 31719625
Infect Drug Resist. 2021 Jan 12;14:89-95
pubmed: 33469323
J Clin Microbiol. 2022 Aug 17;60(8):e0043122
pubmed: 35913145
Front Cell Infect Microbiol. 2022 Aug 24;12:957287
pubmed: 36093181
mBio. 2022 Nov 3;13(6):e0270122
pubmed: 36326252
Germs. 2020 Jun 02;10(2):81-87
pubmed: 32656104
Nat Protoc. 2013 Jun;8(6):1100-13
pubmed: 23680982
Tuberculosis (Edinb). 2014 Sep;94(5):511-8
pubmed: 25130623
PLoS One. 2021 May 17;16(5):e0251422
pubmed: 33999938
Sci Rep. 2021 Mar 22;11(1):6493
pubmed: 33753820
Front Cell Infect Microbiol. 2023 Jan 12;12:1064148
pubmed: 36710965
J Antimicrob Chemother. 2014 Feb;69(2):437-40
pubmed: 24072170
PLoS One. 2022 Jan 13;17(1):e0262123
pubmed: 35025930
J Clin Microbiol. 2019 Feb 27;57(3):
pubmed: 30541931
Sci Transl Med. 2021 Nov 24;13(621):eabg2612
pubmed: 34818059
Respiration. 2022;101(9):797-813
pubmed: 35760050
BMC Res Notes. 2019 Jun 20;12(1):349
pubmed: 31221195
J Clin Med. 2020 Dec 21;9(12):
pubmed: 33371314
Public Health Action. 2020 Mar 21;10(1):11-16
pubmed: 32368518
PLoS One. 2018 Jan 22;13(1):e0190988
pubmed: 29357378
J Clin Tuberc Other Mycobact Dis. 2020 Feb 04;19:100148
pubmed: 32099908
J Dent Res. 2016 Apr;95(4):365-71
pubmed: 26747422
J Clin Med. 2021 Jul 23;10(15):
pubmed: 34362035
Front Public Health. 2015 Dec 23;3:281
pubmed: 26779470
Tuberculosis (Edinb). 2020 Sep;124:101945
pubmed: 32692652
Int J Oral Sci. 2016 Sep 29;8(3):133-7
pubmed: 27585820
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1532-1540
pubmed: 27387272
JACS Au. 2021 Jul 26;1(9):1368-1379
pubmed: 34604847
Science. 1997 May 30;276(5317):1420-2
pubmed: 9162010
Int J Mycobacteriol. 2016 Dec;5(4):374-378
pubmed: 27931676
Front Cell Infect Microbiol. 2021 Jun 14;11:696379
pubmed: 34195103
Tuberculosis (Edinb). 2021 Jul;129:102103
pubmed: 34144375
Sci Rep. 2019 Jul 25;9(1):10789
pubmed: 31346252
Clin Infect Dis. 2022 Dec 19;75(12):2145-2152
pubmed: 35579497
Am J Respir Crit Care Med. 2010 Jan 15;181(2):174-80
pubmed: 19875686
J Clin Microbiol. 2022 Jul 20;60(7):e0042122
pubmed: 35758702
PLoS One. 2020 Oct 30;15(10):e0241542
pubmed: 33125422
Sci Transl Med. 2018 Feb 28;10(430):
pubmed: 29491187
Sci Rep. 2015 Mar 02;5:8668
pubmed: 25727773
Am J Respir Crit Care Med. 2018 Mar 15;197(6):818-821
pubmed: 28880570
Sci Rep. 2020 Dec 17;10(1):22231
pubmed: 33335256
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0060821
pubmed: 34060896